Celiac disease and the risk of pancreatitis: new clinical evidence

Celiac disease is a systemic autoimmune condition associated with numerous extra-intestinal manifestations. In addition to involvement of the small intestine, an increased risk of diseases affecting various organs has been documented in people with celiac disease, confirming the systemic nature of the condition.

A recent population-based observational study, published in the World Journal of Clinical Cases, assessed the long-term risk of acute and chronic pancreatitis in patients with celiac disease, comparing it with a cohort of individuals without a diagnosis of celiac disease.

The results show that patients with celiac disease have a significantly increased risk of developing pancreatitis compared with controls. In particular, the risk of acute pancreatitis is more than doubled, whilst that of chronic pancreatitis is moderately but significantly higher.

The association remains consistent across different sensitivity analyses and the various time intervals considered, suggesting a robust link between celiac disease and pancreatic disease.

A key finding emerging from the study is that the increased risk applies to various aetiologies of pancreatitis, including biliary, alcohol-related and idiopathic forms. This finding suggests that the association is not limited to the main traditional risk factors.

The results reinforce the hypothesis of a systemic involvement of celiac disease, potentially mediated by chronic immunological and inflammatory mechanisms, as well as by nutritional deficiencies and persistent alterations in the intestinal mucosa. In this context, the gut-pancreas axis emerges as a possible key element in the pathophysiology.

This large population-based analysis provides strong evidence of an association between celiac disease and an increased risk of acute and chronic pancreatitis. Further prospective studies will be needed to clarify the underlying pathophysiological mechanisms and to define targeted prevention and monitoring strategies in patients with celiac disease.